Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.52 |
| ▸ | HPGD | P15428 | 9/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 7/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | MPO | P05164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5415081 | 0.84 | KDM4E (0.54) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL31276567 | 0.84 | KDM4E (0.54) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL3155318 | 0.82 | KDM4E (0.56) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL3235570 | 0.81 | KDM4E (0.50) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL8742102 | 0.79 | ALDH1A1 (0.72) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL10880796 | 0.79 | KDM4E (0.48) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL31251472 | 0.79 | ALDH1A1 (0.72) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL15568422 | 0.78 | ALDH1A1 (0.78) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL27871001 | 0.78 | ALDH1A1 (0.78) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL1685076 | 0.78 | HPGD (0.46) | KDM4EHPGDALDH1A1SMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255228-A1 | Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| US-7427690-B2 | Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration | BIODERM RESEARCH (US) | 2008-09-23 | — | — | US | claimed |
| US-20070099886-A1 | Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration | BIODERM RESEARCH (US) | 2007-05-03 | — | — | US | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| US-20050271608-A1 | Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives | GUPTA SHYAM K | 2005-12-08 | — | — | US | claimed |
| US-8227426-B2 | Chiral complexes of ascorbic acid with natural antioxidant and anti-inflammatory ketones including aloe, citrus, ginger, and mango for skin and hair care | ISLAND KINETICS INC. (US) | 2012-07-24 | — | — | US | disclosed |
| US-20110059907-A1 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care | ISLAND KINETICS INC. (US) | 2011-03-10 | — | — | US | disclosed |
| US-7834210-B2 | Hair loss prevention by natural amino acid and peptide complexes | BIODERM RESEARCH (US) | 2010-11-16 | — | — | US | disclosed |
| US-7777073-B2 | Topical delivery system for antiaging and skin whitening agents | BIODERM RESEARCH (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090253668-A1 | Hair Loss Prevention by Natural Amino Acid and Peptide Complexes | BIODERM RESEARCH (US) | 2009-10-08 | — | — | US | disclosed |
| US-7572933-B2 | Skin and hair restoration by natural amino acid peptide complexes | BIODERM RESEARCH (US) | 2009-08-11 | — | — | US | disclosed |
| US-20090130154-A1 | Topical Delivery of Biological and Cosmetic Agents by Zeolites | BIODERM RESEARCH (US) | 2009-05-21 | — | — | US | disclosed |
| US-20080255228-A1 | Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | disclosed |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | disclosed |
| US-7427690-B2 | Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration | BIODERM RESEARCH (US) | 2008-09-23 | — | — | US | disclosed |
| US-20080139507-A1 | Method of Treating Skin Condition Including Acne, Skin Aging, Body Odor & Diaper Rash by Zinc Zeolite Clathrates | BIODERM RESEARCH (US) | 2008-06-12 | — | — | US | disclosed |
| US-20070099886-A1 | Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration | BIODERM RESEARCH (US) | 2007-05-03 | — | — | US | disclosed |
| US-5432014-A | Flat display element | SANYO ELECTRIC CO., LTD. (JP) | 1995-07-11 | — | — | US | disclosed |
| US-3985783-A | Process for ring acylation of phenols | THE DOW CHEMICAL COMPANY (US) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059907-A1 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care | GLA, LPO, PLOD3 | KDM4E 1594/4885HPGD 774/4885ALDH1A1 110/4885 |
| US-20090130154-A1 | Topical Delivery of Biological and Cosmetic Agents by Zeolites | TYR, MMP1, MMP17 | KDM4E 1764/4885HPGD 3845/4885ALDH1A1 1967/4885 |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | PSMB1, PLOD3, CUTA | KDM4E 513/4885HPGD 1094/4885ALDH1A1 330/4885 |
| US-20090253668-A1 | Hair Loss Prevention by Natural Amino Acid and Peptide Complexes | MMP1, MMP17, MMP13 | KDM4E 3063/4885HPGD 861/4885ALDH1A1 1360/4885 |
| US-20080255228-A1 | Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles | PROC, COL1A1, CUTA | KDM4E 1689/4885HPGD 725/4885ALDH1A1 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.